Allosteric modulators affect the internalization of human adenosine A1 receptors

Area of Science:

• Pharmacology
• Cell Biology
• Biochemistry

Background:

• Adenosine A(1) receptors play crucial roles in various physiological processes.
• Understanding receptor internalization mechanisms is key to developing targeted therapeutics.
• Allosteric modulators offer precise control over receptor function.

Purpose of the Study:

• To investigate the influence of allosteric modulators on human adenosine A(1) receptor internalization.
• To determine the effects of an allosteric enhancer (PD 81,723) and an allosteric inhibitor (SCH-202676) on receptor trafficking.

Main Methods:

• Human adenosine A(1) receptors were tagged with yellow fluorescent protein (YFP) without altering binding properties.
• Stable Chinese Hamster Ovary (CHO) cell lines expressing the YFP-tagged receptor were utilized.
• Cells were treated with varying concentrations of the agonist N(6)-cyclopentyladenosine (CPA) alone or in combination with allosteric modulators.

Main Results:

• N(6)-cyclopentyladenosine (CPA) alone induced 25% and 40% receptor internalization at 400 nM and 4 μM, respectively.
• The allosteric enhancer PD 81,723 potentiated CPA-induced internalization, with significant internalization observed at lower CPA concentrations (40 nM).
• The allosteric inhibitor SCH-202676 effectively prevented CPA-mediated internalization of adenosine A(1) receptors.

Conclusions:

• Allosteric modulators play a critical role in regulating adenosine A(1) receptor internalization.
• PD 81,723 enhances agonist-induced internalization, suggesting a role in receptor trafficking.
• SCH-202676 acts as an effective inhibitor of adenosine A(1) receptor internalization, highlighting its potential therapeutic applications.